Trent Limited, Berger Paints, and Alkem Laboratories: Stock Market Surge Explained

Discover why Trent Limited, Berger Paints, and Alkem Laboratories are the talk of the town in the financial world. Learn about their remarkable stock price movements and Q2 results in today's market

Trent Limited's Soaring Performance

Trent Ltd's shares climbed by an impressive 2.20%, reaching Rs 2481.55 per share today, fueled by robust Q2 results.

Trent Ltd's Q2 Profit Leap

In Q2 of FY24, Trent Limited witnessed a staggering 55.9% increase in consolidated net profit, reaching Rs 289.6 crore compared to Rs 186 crore in the previous year's same quarter.

Revenue Growth

The company's total revenue during this period surged by nearly 59%, hitting Rs 2,891 crore.


Trent Limited's EBIDTA skyrocketed by 73% to Rs 461 crore, with an impressive EBIDTA margin of 15.9%, up from 14.7% in the year-ago period.

Berger Paints' Green Territory

Despite no market-sensitive announcements, Berger Paints' shares gained 1.09% today.

Berger Paints' Q2 Success

Berger Paints reported a remarkable 33% jump in consolidated net profit, totaling Rs 292 crore for the second quarter of fiscal year 2023-24.

Revenue on the Rise

During this period, Berger Paints' revenue from operations increased by 3%, reaching Rs 2,767 crore, compared to Rs 2,670.9 crore in the corresponding period last year.

Elevated EBITDA

Berger Paints' EBITDA (excluding other income) for the July-September period surged by 30% to Rs 474 from Rs 364 crore in the same quarter last year.

Alkem Laboratories' Impressive Q2 Results

Alkem Laboratories' shares soared by 4.79% after reporting better-than-expected Q2 results.

Pharma Success Story

In the July-September quarter, Alkem Laboratories saw an 87.5% year-on-year increase in net profit, reaching Rs 620.50 crore in Q2. The company's revenue also grew by almost 12% to Rs 3,440 crore, with a notable expansion of the EBITDA margin to 21.7%.